| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1005989173 |
| P356 | DOI | 10.2165/00003495-199958003-00011 |
| P698 | PubMed publication ID | 10711845 |
| P2093 | author name string | Pazdur R | |
| Hoff PM | |||
| Lassere Y | |||
| P2860 | cites work | Clinical evaluation of ftorafur (pyrimidine-deoxyribose n1-2'-furanidyl-5-fluorouracil) | Q28342351 |
| Effective surgical adjuvant therapy for high-risk rectal carcinoma | Q33387384 | ||
| Cancer statistics, 1998. | Q34065873 | ||
| Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma | Q38207042 | ||
| A review of the United States clinical experience of the fluoropyrimidine, ftorafur (NSC-148958). | Q40260056 | ||
| Experience with UFT in Japan | Q40870630 | ||
| Phase I trials of uracil-tegafur (UFT) using 5 and 28 day administration schedules: demonstration of schedule-dependent toxicities | Q40927573 | ||
| Phase ii evaluation of ftorafur in previously untreated colorectal cancer: A southwest oncology group study | Q41062449 | ||
| Effect of coadministration of uracil or cytosine on the anti-tumor activity of clinical doses of 1-(2-tetrahydrofuryl)-5-fluorouracil and level of 5-fluorouracil in rodents | Q41079432 | ||
| Pharmacokinetics of Leucovorin Metabolites in Human Plasma as a Function of Dose Administrated Orally and Intravenously | Q41135720 | ||
| Preoperative combined oral UFT plus leucovorin and radiation therapy for rectal cancer | Q42666008 | ||
| A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study | Q44583571 | ||
| Analogs of pyrimidine nucleosides. I. N1-(alpha-furanidyl) derivatives of natural pyrimidine bases and their antimetabolities | Q44663361 | ||
| Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study | Q44664927 | ||
| Phase I and pharmacokinetic study of oral UFT, a combination of the 5-fluorouracil prodrug tegafur and uracil. | Q46052099 | ||
| Uracil and tegafur modulated with leucovorin: an effective regimen with low toxicity for the treatment of colorectal carcinoma in the elderly. Oncopaz Cooperative Group. | Q50956129 | ||
| Impact of protracted venous infusion fluorouracil with or without interferon alfa-2b on tumor response, survival, and quality of life in advanced colorectal cancer. | Q53639104 | ||
| Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer | Q59647361 | ||
| Effect of uracil and its derivatives on antitumor activity of 5-fluorouracil and 1-(2-tetrahydrofuryl)-5-fluorouracil | Q67448566 | ||
| Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project | Q68056139 | ||
| Phase I-II studies of oral tegafur (ftorafur) | Q70467257 | ||
| A phase I and pharmacokinetic study of oral uracil, ftorafur, and leucovorin in patients with advanced cancer | Q71032345 | ||
| Efficacy of oral tegafur modulation by uracil and leucovorin in advanced colorectal cancer. A phase II study | Q71127386 | ||
| Thymidylate synthase inhibition by an oral regimen consisting of tegafur-uracil (UFT) and low-dose leucovorin for patients with gastric cancer | Q71422133 | ||
| Activation of Ftorafue [R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil] to 5-fluorouracil and gamma-butyrolactone | Q71507649 | ||
| [Concentration of 5-FU level in the tissue and blood of the patients with breast cancer by preoperative administration of UFT] | Q71648639 | ||
| Mechanism-based improvement in the therapeutic selectivity of 5-FU prodrug alone and under conditions of metabolic modulation | Q71934546 | ||
| Clinical application of biochemical modulation in cancer chemotherapy: biochemical modulation for 5-FU | Q71934549 | ||
| Biochemical factors affecting the tightness of 5-fluorodeoxyuridylate binding to human thymidylate synthetase | Q72004501 | ||
| A fixed-ratio combination of uracil and Ftorafur (UFT) with low dose leucovorin. An active oral regimen for advanced colorectal cancer | Q72425285 | ||
| Tegafur-uracil (UFT) plus folinic acid in advanced rectal cancer | Q72430744 | ||
| Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report | Q72525174 | ||
| Phase II trial of uracil and tegafur plus oral leucovorin: an effective oral regimen in the treatment of metastatic colorectal carcinoma | Q72816296 | ||
| Phase I trial of uracil-tegafur (UFT) plus oral leucovorin: 14-day schedule | Q73504125 | ||
| P921 | main subject | colorectal cancer | Q188874 |
| fluorouracil | Q238512 | ||
| colorectal carcinoma | Q25493920 | ||
| P304 | page(s) | 77-83 | |
| P577 | publication date | 1999-01-01 | |
| P1433 | published in | Drugs | Q3040094 |
| P1476 | title | Tegafur/uracil + calcium folinate in colorectal cancer: double modulation of fluorouracil | |
| P478 | volume | 58 Suppl 3 |
| Q33370792 | A phase I dose-finding clinical pharmacokinetic study of an oral formulation of irinotecan (CPT-11) administered for 5 days every 3 weeks in patients with advanced solid tumours |
| Q36859180 | A phase II study of UFT with leucovorin administered as a twice daily schedule in the treatment of patients with metastatic colorectal cancer. |
| Q33859998 | Improving fluorouracil chemotherapy with novel orally administered fluoropyrimidines |
| Q33859915 | Oral alkylating agents for breast cancer therapy |
| Q33341415 | Oral tegafur/uracil |
| Q34979779 | Oxaliplatin: results in colorectal carcinoma. |
| Q47951123 | Screening of the structural, topological, and electronic properties of the functionalized Graphene nanosheets as potential Tegafur anticancer drug carriers using DFT method. |
| Q35041996 | TEGAFIRI is an effective alternative regimen for the management of recurrent or metastatic colorectal cancer |
Search more.